These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 5578236

  • 1. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
    Watanabe AM, Parks LC, Kopin IJ.
    J Clin Invest; 1971 Jun; 50(6):1322-8. PubMed ID: 5578236
    [Abstract] [Full Text] [Related]

  • 2. Effect of L-dopa on plasma renin activity with and without inhibition of extracerebral dopa decarboxylase in dogs.
    Blair ML, Reid IA, Ganong WF.
    J Pharmacol Exp Ther; 1977 Jul; 202(1):209-15. PubMed ID: 874815
    [Abstract] [Full Text] [Related]

  • 3. The cardiovascular pharmacology of L(--)-dopa: peripheral and central effects.
    Osborne MW, Wenger JJ, Willems W.
    J Pharmacol Exp Ther; 1971 Sep; 178(3):517-28. PubMed ID: 5571901
    [No Abstract] [Full Text] [Related]

  • 4. Centrally mediated increased reflex vagal bradycardia after L-dopa in monoamine oxidase-inhibited anesthetized dogs.
    Antonaccio MJ, Kerwin L.
    J Pharmacol Exp Ther; 1976 Feb; 196(2):380-8. PubMed ID: 1255483
    [Abstract] [Full Text] [Related]

  • 5. Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase.
    Bartholini G, Pletscher A.
    J Pharmacol Exp Ther; 1968 May; 161(1):14-20. PubMed ID: 5648492
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. On the mechanism of L-dopa-induced postural hypotension in the cat.
    Dhasmana KM, Spilker BA.
    Br J Pharmacol; 1973 Mar; 47(3):437-51. PubMed ID: 4147189
    [Abstract] [Full Text] [Related]

  • 12. [Potentiation of the central effect of DOPA after selective inhibition of extracerebral decarboxylase].
    Gaillard JM, Schaeppi R, Tissot R.
    Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):423-37. PubMed ID: 5348411
    [No Abstract] [Full Text] [Related]

  • 13. gamma-Glutamyl dopa: a kidney-specific dopamine precursor.
    Wilk S, Mizoguchi H, Orlowski M.
    J Pharmacol Exp Ther; 1978 Jul; 206(1):227-32. PubMed ID: 660553
    [Abstract] [Full Text] [Related]

  • 14. L-dopa: its effect on the cardiovascular system.
    Carrasco HA, Lozano J, Lang TW, Meerbaum S.
    Geriatrics; 1971 Sep; 26(9):100-8. PubMed ID: 5125691
    [No Abstract] [Full Text] [Related]

  • 15. [Progress in the therapy of parkinsonism with L-dopa: inhibition of dopa decarboxylase].
    Nurzia A.
    Clin Ter; 1975 Feb 15; 72(3):289-95. PubMed ID: 1132216
    [No Abstract] [Full Text] [Related]

  • 16. Role of monoamine neural systems in L-dihydroxyphenylalanine-stimulated activity.
    Hollister AS, Breese GR, Mueller RA.
    J Pharmacol Exp Ther; 1979 Jan 15; 208(1):37-43. PubMed ID: 759613
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent.
    Hornykiewicz O.
    Amino Acids; 2002 Jan 15; 23(1-3):65-70. PubMed ID: 12373520
    [Abstract] [Full Text] [Related]

  • 19. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
    Olsen NV.
    Dan Med Bull; 1998 Jun 15; 45(3):282-97. PubMed ID: 9675540
    [Abstract] [Full Text] [Related]

  • 20. Effects of L-dopa on myocardial contractile force: a reappraisal.
    Wenger JJ, Osborne MW.
    Arch Int Pharmacodyn Ther; 1975 Oct 15; 217(2):251-6. PubMed ID: 1190920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.